Baxter International
BAXTER INTERNATIONAL develops Healthcare Products, Medical Devices with headquarters is in USA. Develops healthcare products related to kidney diseases and immunity disorders.
BAXTER INTERNATIONAL PRODUCTS:
World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.
BAXTER INTERNATIONAL develops Healthcare Products, Medical Devices with headquarters is in USA. Develops healthcare products related to kidney diseases and immunity disorders.
BAXTER INTERNATIONAL PRODUCTS:
Charles River Laboratories is a Healthcare and pharmaceutical company. The company products and services are Research animals models, genetically engineered model and services, animal health, surveillance, surgery and precondition service, generic testing services and Insourcing solutions. The headquarters is in USA.
The company currently operated 110 facilities in 20 countries.
Charles River Laboratories annual revenue generated for period ending Dec-2022 was 3,976 million USD.
Charles River Laboratories annual net income generated for period ending Dec-2022 was 486 million USD.
Charles River Laboratories annual revenue generated for period ending Dec-2021 was 3,540 million USD.
Charles River Laboratories annual net income generated for period ending Dec-2021 was 391 million USD.
CSPC Pharmaceutical Group Limited is a pharmaceutical group in China. CSPC mainly owns two business segments of finished drugs and bulk drugs. Headquarters is in China.
Biomarin Pharmaceutical is Pharmaceutical and Biotechnology Company with headquarters is in California, USA.
It develops innovate therapies and life-threatening rare diseases and medical conditions.It consists of seven commercial products for the treatment of various diseases.
As on 2022, Biomarin Pharmaceutical has 3,082 employees.
Biomarin Pharmaceutical annual revenue generated for period ending Dec-2022 was 2,096 million USD.
Recordati Industria Chimica e Farmaceutica is a Pharmaceutical Multinational company. The company is a leader in the treatment of rare diseases and orphan drugs, has successfully implemented its strategy of establishing a direct presence in the main markets of all continents as per 2019. It is having more than 4,300 employees, which is dedicated to research, development, production and marketing of pharmaceutical products, consolidated revenues in 2019 were € 1,481.8 million, operating profit was € 465.3 million and net income was € 368.9 million. The headquarters is in Italy.
Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd is a Pharmaceutical company. The company has 34 holding subsidiaries, 8 joint stock companies and 4 industry funds with more than 2,100 employees. The headquarters is in China.